324 related articles for article (PubMed ID: 21346189)
1. HIV-1 requires Arf6-mediated membrane dynamics to efficiently enter and infect T lymphocytes.
García-Expósito L; Barroso-González J; Puigdomènech I; Machado JD; Blanco J; Valenzuela-Fernández A
Mol Biol Cell; 2011 Apr; 22(8):1148-66. PubMed ID: 21346189
[TBL] [Abstract][Full Text] [Related]
2. A Membrane-Anchored Short-Peptide Fusion Inhibitor Fully Protects Target Cells from Infections of Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.
Tang X; Jin H; Chen Y; Li L; Zhu Y; Chong H; He Y
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462566
[TBL] [Abstract][Full Text] [Related]
3. Role of HIV-1 subtype C envelope V3 to V5 regions in viral entry, coreceptor utilization and replication efficiency in primary T-lymphocytes and monocyte-derived macrophages.
Sundaravaradan V; Das SR; Ramakrishnan R; Sehgal S; Gopalan S; Ahmad N; Jameel S
Virol J; 2007 Nov; 4():126. PubMed ID: 18036244
[TBL] [Abstract][Full Text] [Related]
4. A recombinant vesicular stomatitis virus encoding CCR5-tropic HIV-1 receptors targets HIV-1-infected cells and controls HIV-1 infection.
Okuma K; Fukagawa K; Kohma T; Takahama Y; Hamaguchi Y; Ito M; Tanaka Y; Buonocore L; Rose JK; Hamaguchi I
Microbes Infect; 2017; 19(4-5):277-287. PubMed ID: 28025070
[TBL] [Abstract][Full Text] [Related]
5. Moesin is required for HIV-1-induced CD4-CXCR4 interaction, F-actin redistribution, membrane fusion and viral infection in lymphocytes.
Barrero-Villar M; Cabrero JR; Gordón-Alonso M; Barroso-González J; Alvarez-Losada S; Muñoz-Fernández MA; Sánchez-Madrid F; Valenzuela-Fernández A
J Cell Sci; 2009 Jan; 122(Pt 1):103-13. PubMed ID: 19066282
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells.
Popik W; Alce TM; Au WC
J Virol; 2002 May; 76(10):4709-22. PubMed ID: 11967288
[TBL] [Abstract][Full Text] [Related]
7. Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases.
Wilen CB; Wang J; Tilton JC; Miller JC; Kim KA; Rebar EJ; Sherrill-Mix SA; Patro SC; Secreto AJ; Jordan AP; Lee G; Kahn J; Aye PP; Bunnell BA; Lackner AA; Hoxie JA; Danet-Desnoyers GA; Bushman FD; Riley JL; Gregory PD; June CH; Holmes MC; Doms RW
PLoS Pathog; 2011 Apr; 7(4):e1002020. PubMed ID: 21533216
[TBL] [Abstract][Full Text] [Related]
8. The GDP-bound form of Arf6 is located at the plasma membrane.
Macia E; Luton F; Partisani M; Cherfils J; Chardin P; Franco M
J Cell Sci; 2004 May; 117(Pt 11):2389-98. PubMed ID: 15126638
[TBL] [Abstract][Full Text] [Related]
9. A recombinant vesicular stomatitis virus encoding HIV-1 receptors and human OX40 ligand efficiently eliminates HIV-1-infected CD4-positive T cells expressing OX40.
Tsuruno C; Okuma K; Takahashi Y; Tanaka R; Tanaka Y; Takahama Y; Hamaguchi Y; Hamaguchi I; Yamaguchi K
Hum Immunol; 2011 Apr; 72(4):295-304. PubMed ID: 21262309
[TBL] [Abstract][Full Text] [Related]
10. CD4-Dependent Modulation of HIV-1 Entry by LY6E.
Yu J; Liang C; Liu SL
J Virol; 2019 Apr; 93(7):. PubMed ID: 30674630
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 entry in SupT1-R5, CEM-ss, and primary CD4+ T cells occurs at the plasma membrane and does not require endocytosis.
Herold N; Anders-Ößwein M; Glass B; Eckhardt M; Müller B; Kräusslich HG
J Virol; 2014 Dec; 88(24):13956-70. PubMed ID: 25253335
[TBL] [Abstract][Full Text] [Related]
12. Envelope-dependent restriction of human immunodeficiency virus type 1 spreading in CD4(+) T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulation.
Vicenzi E; Bordignon PP; Biswas P; Brambilla A; Bovolenta C; Cota M; Sinigaglia F; Poli G
J Virol; 1999 Sep; 73(9):7515-23. PubMed ID: 10438841
[TBL] [Abstract][Full Text] [Related]
13. CXCR6-Mediated Simian Immunodeficiency Virus SIVagmSab Entry into Sabaeus African Green Monkey Lymphocytes Implicates Widespread Use of Non-CCR5 Pathways in Natural Host Infections.
Wetzel KS; Yi Y; Elliott STC; Romero D; Jacquelin B; Hahn BH; Muller-Trutwin M; Apetrei C; Pandrea I; Collman RG
J Virol; 2017 Feb; 91(4):. PubMed ID: 27903799
[TBL] [Abstract][Full Text] [Related]
14. P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions.
Giroud C; Marin M; Hammonds J; Spearman P; Melikyan GB
J Virol; 2015 Sep; 89(18):9368-82. PubMed ID: 26136569
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 sexual transmission: early events of HIV-1 infection of human cervico-vaginal tissue in an optimized ex vivo model.
Saba E; Grivel JC; Vanpouille C; Brichacek B; Fitzgerald W; Margolis L; Lisco A
Mucosal Immunol; 2010 May; 3(3):280-90. PubMed ID: 20147895
[TBL] [Abstract][Full Text] [Related]
16. The HIV envelope but not VSV glycoprotein is capable of mediating HIV latent infection of resting CD4 T cells.
Yu D; Wang W; Yoder A; Spear M; Wu Y
PLoS Pathog; 2009 Oct; 5(10):e1000633. PubMed ID: 19851458
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Fusion with CD4+ T cells Is Promoted by Proteins Involved in Endocytosis and Intracellular Membrane Trafficking.
Marin M; Kushnareva Y; Mason CS; Chanda SK; Melikyan GB
Viruses; 2019 Jan; 11(2):. PubMed ID: 30691001
[TBL] [Abstract][Full Text] [Related]
18. P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection.
Swartz TH; Esposito AM; Durham ND; Hartmann BM; Chen BK
J Virol; 2014 Oct; 88(19):11504-15. PubMed ID: 25031337
[TBL] [Abstract][Full Text] [Related]
19. Primary human mammary epithelial cells endocytose HIV-1 and facilitate viral infection of CD4+ T lymphocytes.
Dorosko SM; Connor RI
J Virol; 2010 Oct; 84(20):10533-42. PubMed ID: 20702626
[TBL] [Abstract][Full Text] [Related]
20. Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7.
Parrish NF; Wilen CB; Banks LB; Iyer SS; Pfaff JM; Salazar-Gonzalez JF; Salazar MG; Decker JM; Parrish EH; Berg A; Hopper J; Hora B; Kumar A; Mahlokozera T; Yuan S; Coleman C; Vermeulen M; Ding H; Ochsenbauer C; Tilton JC; Permar SR; Kappes JC; Betts MR; Busch MP; Gao F; Montefiori D; Haynes BF; Shaw GM; Hahn BH; Doms RW
PLoS Pathog; 2012; 8(5):e1002686. PubMed ID: 22693444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
